Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacodynamics of Liposomal Bupivacaine for Peripheral Nerve Blockade
2023-000035-74Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, triple-blind trial of bupivacaine in procedural pain (2 arms), sponsored by Medical University of Vienna. Primary endpoint: Duration of sensory nerve blockade. Started Jan 2023; status: completed.
02
Drugs
bupivacaine
03
Conditions
procedural pain
Beyond the preview
Go deeper on 2023-000035-74.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-000035-74.